J.G.Chemicals

Why is J.G.Chemicals Ltd falling/rising?

As of 18-Aug, J.G.Chemicals Ltd's stock price has risen to 645.15, reflecting a 7.09% increase, driven by strong historical performance and positive investor sentiment. Despite a decline in investor participation, the stock remains liquid and has outperformed the broader market and its sector.

As of 18-Aug, J.G.Chemicals Ltd is experiencing a rise in its stock price, currently at 645.15, which reflects an increase of 42.7 or 7.09%. This upward movement can be attributed to several factors. <BR><BR>Firstly, the stock has shown strong performance over various periods, with a notable increase of 45.01% over the past month, significantly outperforming the Sensex, which declined by 1.17% during the same timeframe. Year-to-date, the stock has risen by 82.89%, while the Sensex has fallen by 9.37%, indicating robust investor interest and confidence in J.G.Chemicals Ltd compared to the broader market.<BR><BR>Additionally, today's performance highlights that the stock has outperformed its sector by 6.53%, suggesting positive sentiment among investors. The stock has also shown a trend reversal, gaining after two consecutive days of decline, which may indicate a recovery phase. Furthermore, it is trading above its moving averages across various time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, reinforcing the bullish trend.<BR><BR>However, it is important to note that there has been a decline in investor participation, with delivery volume dropping by 62.53% against the 5-day average. Despite this, the stock remains liquid enough for trading, which may help sustain its current price level.<BR><BR>Overall, the combination of strong historical performance, sector outperformance, and recovery from recent declines contributes to the rising stock price of J.G.Chemicals Ltd.

Which are the latest news on J.G.Chemicals?

What does J.G.Chemicals do?

J.G.Chemicals Ltd is a micro-cap company in the commodity chemicals industry, formed in 1975 and registered as a private limited company in 2001, with recent quarterly net sales of 316 Cr and net profit of 25 Cr as of June 2026. Key financial metrics include a market cap of INR 2,370 Cr, P/E of 32.00, and a return on equity of 12.47%.

Overview:<BR>J.G.Chemicals Ltd operates in the commodity chemicals industry and is classified as a micro-cap company.<BR><BR>History:<BR>The company was initially formed as a Partnership Firm on March 15, 1975, under the name "J.G.Chemicals" in West Bengal. It transitioned to a joint stock company and was registered as a Private Limited Company on June 28, 2001. The latest quarterly results reported net sales and net profit for June 2026.<BR><BR>Financial Snapshot:<BR>- Net Sales: 316 Cr (Quarterly Results - Jun 2026)<BR>- Net Profit: 25 Cr (Quarterly Results - Jun 2026)<BR>- Market Cap: INR 2,370 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>- P/E: 32.00<BR>- Industry P/E: 44<BR>- Dividend Yield: 0.00%<BR>- Debt Equity: -0.29<BR>- Return on Equity: 12.47%<BR>- Price to Book: 4.47<BR><BR>Contact Details:<BR>Registrar Address: Not available.

Who are the peers of the J.G.Chemicals?

J.G.Chemicals' peers include GHCL, Grauer & Weil, Chemplast Sanmar, Fischer Medical, Thirumalai Chem., I G Petrochems, Indo Borax & Ch., Andhra Sugars, and TGV Sraac. Notably, Indo Borax & Ch. has the highest 1-year return at 67.70%, while Chemplast Sanmar has the lowest at -56.53%, with J.G.Chemicals at 25.90%.

Peers: The peers of J.G.Chemicals are GHCL, Grauer & Weil, Chemplast Sanmar, Fischer Medical, Thirumalai Chem., I G Petrochems, Indo Borax & Ch., Andhra Sugars, and TGV Sraac.<BR><BR>Quality Snapshot: Excellent management risk is observed at GHCL and Chemplast Sanmar, while Average management risk is found at Grauer & Weil, Fischer Medical, Thirumalai Chem., I G Petrochems, Indo Borax & Ch., and TGV Sraac, and the rest. Below Average management risk is noted at Andhra Sugars. Growth is rated as Excellent for Fischer Medical, Good for J.G.Chemicals, and Below Average for GHCL, Grauer & Weil, Chemplast Sanmar, Thirumalai Chem., I G Petrochems, Indo Borax & Ch., and TGV Sraac, and the rest. Capital Structure is Excellent for GHCL, Grauer & Weil, I G Petrochems, Indo Borax & Ch., and Andhra Sugars, Good for Fischer Medical and TGV Sraac, and Below Average for Chemplast Sanmar and Thirumalai Chem.<BR><BR>Return Snapshot: Indo Borax & Ch. has the highest 1-year return at 67.70%, while Chemplast Sanmar has the lowest at -56.53%. J.G.Chemicals has a 1-year return of 25.90%, which is significantly higher than Chemplast Sanmar but lower than Indo Borax & Ch. Additionally, peers with negative six-month returns include Chemplast Sanmar, Fischer Medical, Thirumalai Chem., and TGV Sraac.

How big is J.G.Chemicals?

As of 14th August, J.G.Chemicals Ltd has a market capitalization of 2,371.74 Cr, with recent net sales of 1,070.57 Cr and a net profit of 75.18 Cr.

As of 14th August, J.G.Chemicals Ltd has a market capitalization of 2,371.74 Cr and is classified as a Micro Cap company.<BR><BR>In the latest four quarters, J.G.Chemicals reported Net Sales of 1,070.57 Cr and a Net Profit of 75.18 Cr.<BR><BR>The latest annual period for the balance sheet is March 2025, showing Shareholder's Funds of 464.75 Cr and Total Assets of 497.93 Cr.

Should I buy, sell or hold J.G.Chemicals Ltd?

Are J.G.Chemicals Ltd latest results good or bad?

J.G.Chemicals Ltd's latest results show strong revenue growth with a record ₹286.17 crores in Q4 FY26, but declining operating margins and slower profit growth indicate operational challenges. Investors should remain cautious and watch for management's response to these issues.

J.G.Chemicals Ltd's latest results present a mixed picture. On one hand, the company achieved its highest-ever quarterly revenue of ₹286.17 crores in Q4 FY26, reflecting a robust year-on-year growth of 27.61% and a sequential increase of 15.17%. This indicates strong demand and operational scaling within the commodity chemicals sector.<BR><BR>However, profitability metrics reveal some challenges. The consolidated net profit for the quarter was ₹18.21 crores, which, while representing an 18.63% increase year-on-year, only grew by 4.06% compared to the previous quarter. More concerning is the decline in operating margins, which fell to 7.51%, down from 9.16% in the previous quarter and 8.69% a year ago. This margin compression suggests the company is facing pressures related to raw material costs, competitive pricing, or operational inefficiencies.<BR><BR>In summary, while J.G.Chemicals has demonstrated impressive revenue growth, the declining margins and slower profit growth indicate that the company is currently grappling with significant operational challenges. Investors should be cautious and monitor how management addresses these margin pressures moving forward.

Is J.G.Chemicals technically bullish or bearish?

As of December 2, 2025, J.G.Chemicals shows a mildly bullish trend supported by daily moving averages and weekly Dow Theory, though caution is advised due to bearish signals from the MACD and Bollinger Bands.

As of 2 December 2025, the technical trend for J.G.Chemicals has changed from sideways to mildly bullish. The daily moving averages indicate a mildly bullish stance, while the weekly Dow Theory also supports this with a mildly bullish signal. However, the weekly MACD and Bollinger Bands are bearish, which suggests some caution. The RSI shows no signal on both weekly and monthly time frames. Overall, the current technical stance is mildly bullish, driven primarily by the daily moving averages and weekly Dow Theory, despite some bearish indicators in the MACD and Bollinger Bands.

How has been the historical performance of J.G.Chemicals?

J.G.Chemicals has shown strong historical performance with increasing net sales and profitability, reporting net sales of 847.94 crore and a profit after tax of 66.76 crore in fiscal year 2025. Despite challenges in cash flow, the company achieved significant growth compared to previous years.

Answer:<BR>The historical performance of J.G.Chemicals shows a trend of increasing net sales and profitability over the past three fiscal years, with significant growth in 2025.<BR><BR>Breakdown:<BR>In the fiscal year ending March 2025, J.G.Chemicals reported net sales of 847.94 crore, a notable increase from 667.69 crore in March 2024 and 784.58 crore in March 2023. The total operating income for 2025 matched the net sales at 847.94 crore, while total expenditure, excluding depreciation, rose to 761.83 crore from 622.37 crore in the previous year. Operating profit, excluding other income, surged to 86.11 crore in 2025, up from 45.32 crore in 2024, leading to an operating profit margin of 10.16%. Profit before tax also saw a substantial rise to 89.90 crore in 2025, compared to 43.10 crore in 2024, resulting in a profit after tax of 66.76 crore, up from 32.11 crore the previous year. The consolidated net profit for 2025 was 64.02 crore, reflecting a strong increase from 30.86 crore in 2024. The company's total assets grew to 497.93 crore in 2025, up from 448.33 crore in 2024, while total liabilities increased to 497.93 crore, with a significant reduction in total debt to 0.00 crore. Cash flow from operating activities turned negative at -11.00 crore in 2025, contrasting with a positive cash flow of 75.00 crore in 2024, leading to a closing cash and cash equivalent of 31.00 crore in 2025. Overall, J.G.Chemicals demonstrated robust growth in sales and profitability, despite challenges in cash flow management.

Is J.G.Chemicals overvalued or undervalued?

As of November 27, 2025, J.G.Chemicals is undervalued with a PE ratio of 25.16 and strong growth potential, making it a compelling investment opportunity despite recent stock performance lagging behind the Sensex.

As of 27 November 2025, J.G.Chemicals has moved from an attractive to a very attractive valuation grade. The company is currently undervalued, with a PE ratio of 25.16, an EV to EBITDA of 17.74, and a PEG ratio of 0.25, indicating strong growth potential relative to its price. <BR><BR>In comparison to peers, J.G.Chemicals shows a significantly lower PE ratio than Solar Industries at 91.64 and Gujarat Fluoroch at 56. The company's return on capital employed (ROCE) stands at an impressive 21.67%, further supporting its valuation. Despite recent stock performance lagging behind the Sensex, with a YTD return of -0.95% compared to the Sensex's 9.70%, the underlying fundamentals suggest that J.G.Chemicals presents a compelling investment opportunity.

Who are the top shareholders of the J.G.Chemicals?

The top shareholders of J.G. Chemicals include Vision Projects & Finvest Private Limited with 21.53%, followed by 10 foreign institutional investors holding 6.09%, and the Massachusetts Institute of Technology with 4.2%. Individual investors collectively own 15.94% of the shares.

The top shareholders of J.G. Chemicals include the promoters, who hold the majority of the shares. The promoter with the highest holding is Vision Projects & Finvest Private Limited, which owns 21.53% of the company. Additionally, there are 10 foreign institutional investors (FIIs) that collectively hold 6.09%. The highest public shareholder is the Massachusetts Institute of Technology, which holds 4.2%. Individual investors also have a significant presence, holding 15.94% of the shares.

When is the next results date for J.G.Chemicals?

No Upcoming Board Meetings

Has J.G.Chemicals declared dividend?

No Dividend History Available